Biotech stocks are known for their high volatility and potential for massive gains. The success in the sector often hinges on progressive and often groundbreaking medical advancements. Any concerns relating to upcoming drugs can have severely negative effects on stock prices.As per Precedence Research, the global biotechnology market is projected to grow from $1.38 trillion in 2023 to approximately $4.25 trillion by 2033. The expected growth is largely to be driven by advancements in various biotechnologica ...